Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2019-03-27 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
2018年度募集资金存放与使用情况专项审核报告
Regulatory Filings
2019-03-27 Chinese
关于变更公司法定代表人暨修订《公司章程》的公告
Board/Management Information Classification · 95% confidence The document is an announcement from Zhengzhou Antu Bioengineering Co., Ltd. regarding the change of the company's legal representative and the revision of the company's articles of association. It details specific amendments to the articles, including changes in the legal representative from the chairman to the general manager, and other governance-related provisions. The document is a formal announcement of these changes and the intention to submit the revised articles to the shareholders' meeting for approval and registration with the administrative department. There is no financial data, audit information, or report attached or referenced as being published. The content focuses on governance structure changes and company bylaws revisions, which fits the category of Board/Management Information (MANG). The document length is 3257 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2019-03-27 Chinese
公司章程
Governance Information Classification · 95% confidence The document is titled as the Articles of Association (章程) of 郑州安图生物工程股份有限公司, which is a legal and governance document outlining the company's organizational structure, shareholder rights, board responsibilities, and other corporate governance matters. It includes detailed provisions on shares, shareholder meetings, board of directors, management, financial accounting, and amendments to the articles. This type of document is a governance framework rather than a financial report or announcement. It does not contain financial statements, audit opinions, earnings data, or voting results. It is not a report publication announcement or a regulatory filing in the usual sense but a formal governance document. Therefore, the most appropriate classification is Governance Information (CGR).
2019-03-27 Chinese
2018年度控股股东及其他关联方资金占用情况的专项说明
Regulatory Filings
2019-03-27 Chinese
2018年内部控制审计报告
Regulatory Filings
2019-03-27 Chinese
关于全资子公司完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Zhengzhou Antu Biological Engineering Co., Ltd. regarding the completion of business registration changes for its wholly-owned subsidiaries, including changes in legal representatives and updated business licenses. The content focuses on corporate registration and legal representative changes rather than financial results, management changes at the parent company level, or other report types. It is a regulatory announcement about corporate structure details, not a financial report, management change announcement at the parent company level, or voting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-03-22 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.